01
QAP learned to say NO-GO
How an older signal-led crypto pair CLI evolved into a deterministic research workbench where matched passive controls, realistic costs, and evidence can overrule the model.
Writing
Practical engineering notes, project retrospectives, and explanations of implementation decisions and failures.
01
How an older signal-led crypto pair CLI evolved into a deterministic research workbench where matched passive controls, realistic costs, and evidence can overrule the model.
02
Moving Satori from a connected-vector-store story to a local-first code map forced clearer ownership between source evidence, model-specific vectors, publications, runtime compatibility, and agent-facing tools.
03
How a local X publishing tool grew into a network-growth system with relationship intelligence, writing strategy, measured learning, explicit main-feed approval, and tightly bounded reply automation.
04
What changed when I stopped treating an MCP-to-WSL bridge as a connectivity problem and separated files, Bash, code intelligence, terminal lifetime, browser control, and constrained-client access into explicit authority boundaries.
05
Notes from building AI Studio Prompt Library: scoped MV3 messaging, layered DOM selectors, Angular form events, and user-controlled selector fallbacks.
06
How VoxInfinity turns Inworld AI's homepage TTS widget into a browser-session queue for books, articles, long notes, direct requests, and playback.
07
Why fixed text chunks are weak evidence for code changes, and how Satori combines symbol-aware chunking, hybrid retrieval, freshness checks, and exact bounded reads.
08
How PromptReady moved past generic page cleanup by making local Markdown capture, source metadata, fallback selection, and AI cleanup boundaries explicit.
09
Notes on turning PromptReady's weak page captures into explicit deep-capture policy, rendered fixtures, diagnostics, and repeatable no-network tests.
10
How PromptReady changed AI cleanup from raw HTML rewriting into a quality-gated pass over a local Markdown baseline.
/ Topics